← Back to Search

Vitamin

Hydroxocobalamin for Vasoplegic Syndrome

Phase 2
Waitlist Available
Led By James A. Nelson, M.B.B.S.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This study is evaluating whether a medication may help improve blood pressure for individuals who have had heart surgery.

Eligible Conditions
  • Vasoplegic Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Mean Arterial Pressure
Secondary outcome measures
Change in Norepinephrine Equivalent Infusion Rate. Norepinephrine Equivalent Table is Listed in the Study Protocol
Change in Systolic Blood Pressure
Death
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: B12aExperimental Treatment2 Interventions
Subjects will receive Hydroxocobalamin marketed as Cyanokit®, 5g, IV
Group II: PlaceboPlacebo Group2 Interventions
Subjects will receive placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hydroxocobalamin
FDA approved

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,213 Previous Clinical Trials
3,767,003 Total Patients Enrolled
1 Trials studying Vasoplegic Syndrome
20 Patients Enrolled for Vasoplegic Syndrome
James A. Nelson, M.B.B.S.Principal Investigator - Mayo Clinic
Mayo Clinic Health System-Mankato, St. James Medical Center-Mayo Health System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Vitamin B12a Vasoplegic Syndrome
James A. Nelson 2019. "Vitamin B12a Vasoplegic Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03735316.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top